Back

State-of-the-art lecture on next generation cardiometabolic pharmacology: from lipids to RNA therapeutics

28 August 2026 (08:15 - 08:33)
Organised by: Logo
Congress Presentation Part of: Innovations in lipid lowering and cardiometabolic disease Pharmacology and Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Associate Professor Ann Marie Navar

University of Texas Southwestern Medical Center, Dallas (United States of America)

3 More presentations in this session

Presentation thumbnail
Long-term efficacy and safety of olezarsen in patients with severe hypertriglyceridemia
Doctor R. Giugliano (Boston, US)
Abstract Slides Video
Presentation thumbnail
HTD1801 as a multisystem cardio‑kidney‑metabolic therapy in type 2 diabetes: phase 3 SYMPHONY Trials demonstrate early CKM risk modification
Doctor F. Surmont (Brugge, BE)
Abstract Slides Video
Presentation thumbnail
Ticalicibart monthly as add-on therapy to statins for nonfamilial hypercholesterolemia: the randomized, phase 3 TIMER trial
Doctor C. Xu (CN) Doctor T. Li (Xi'an, CN)
Abstract Video

Access the full session

Session thumbnail
Innovations in lipid lowering and cardiometabolic disease
Video

The Event

Event poster

ESC Congress 2026

28 August 2026 08:15 CET
You may be interested in
thumbnail
Congress Presentation
siRNAs to lower LDL-cholesterol
28 August 2026
thumbnail
Congress Session
Emerging cardiovascular drugs: watch this space
30 August 2024
thumbnail
Congress Presentation
The future of lipid management: novel therapeutics and the path forward
31 August 2025
thumbnail
Congress Presentation
Can gene editing address unmet need in dyslipidaemia?
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources